According to OptimizeRx's latest financial reports the company's current EPS (TTM) is -HK$6.36. In 2022 the company made an earnings per share (EPS) of -HK$4.88 a decrease over its 2021 EPS that were of HK$0.09507.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$6.43 | 31.71% |
2022 | -HK$4.88 | -5237.82% |
2021 | HK$0.09507 | -108.17% |
2020 | -HK$1.16 | -31.65% |
2019 | -HK$1.70 | -1197.3% |
2018 | HK$0.16 | -109.09% |
2017 | -HK$1.71 | 46.67% |
2016 | -HK$1.16 | 137.24% |
2015 | -HK$0.49 | -57.85% |
2014 | -HK$1.16 | 400% |
2013 | -HK$0.23 | -75% |
2012 | -HK$0.93 | -73.33% |
2011 | -HK$3.49 | -0% |
2010 | -HK$3.49 | -59.46% |
2009 | -HK$8.61 | -5.13% |
2008 | -HK$9.07 |